Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalICUI +0.17%81 Days Sales Outstanding is 31.81 as of Jun. 2026, which is 1% above its 10-year median of 31.43. GuruFocus rates ICUI with a GF Score™ of 81/100 and a GF Value™ of $120.64 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 810 Medical Devices & Instruments companies, ICU Medical ranks better than 91.11% on this metric.
ICU Medical's average Accounts Receivable for the
three
months ended in Jun. 2026 was $192 Mil. ICU Medical's Revenue for the
three
months ended in Jun. 2026 was $552 Mil.
Hence, ICU Medical's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 31.81.
The historical rank and industry rank for ICU Medical's Days Sales Outstanding or its related term are showing as below:
ICUI'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 23.84 Med: 31.43 Max: 54.84
Current: 31.64
During the past 13 years, ICU Medical's highest Days Sales Outstanding was 54.84. The lowest was 23.84. And the median was 31.43.
ICUI's Days Sales Outstanding is ranked better than 91.11% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.455
vs ICUI: 31.64
ICU Medical's Days Sales Outstanding
increased
from Jun. 2025 (29.13) to Jun. 2026 (31.81).
ICU Medical (NAS:ICUI) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
ICU Medical Days Sales Outstanding Related Terms
ICU Medical Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for ICU Medical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICUI vs NVST, MMSI, MMED: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, ICU Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where ICU Medical's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (ICUI) has a Days Sales Outstanding of 31.81 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on ICU Medical and its competitors. This is near median its historical median of 31.43. Over the past decade, ICU Medical's Days Sales Outstanding has ranged from 23.84 to 54.84. According to the industry distribution chart, ICU Medical ranks #72 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 8.9%.
Is ICU Medical's Days Sales Outstanding too high?
ICU Medical's current Days Sales Outstanding of 31.81 is near median its 10-year median of 31.43. Over the past 10 years, this metric has ranged from a low of 23.84 to a high of 54.84. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.46. ICU Medical's value of 31.81 is 51.4% below this industry median. Based on the distribution chart, ICU Medical ranks #72 out of 810 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ICU Medical has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's Days Sales Outstanding compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #72 out of 810 companies for Days Sales Outstanding. This places ICU Medical in the top 9% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 65.46. ICU Medical's value of 31.81 is 51.4% below this benchmark. Historically, ICU Medical's own Days Sales Outstanding has ranged from 23.84 to 54.84 over the past decade. While the company's 10-year median is 31.43 vs. the industry median of 65.46, ICU Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.46, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current Days Sales Outstanding of 31.81 is 51.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current Days Sales Outstanding is 31.81, which is near median its own 10-year median of 31.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (ICUI) is currently considered Significantly Overvalued. The stock's GF Value™ is $120.64, compared to a current price of $183.00 — trading 51.7% above its estimated fair value. The current Days Sales Outstanding is 31.81, which is near median its 10-year median of 31.43 and 51.4% below the Medical Devices & Instruments industry median of 65.46. ICU Medical's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For ICU Medical (ICUI), the current Days Sales Outstanding is 31.81 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (ICUI) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of $183.00 is trading 51.7% above its estimated GF Value™ of $120.64.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for ICUI:
Days Sales Outstanding: 31.81 (near median its 10-year median of 31.43)
GF Value™: $120.64 vs. price of $183.00 (51.7% above fair value)
Industry Position: 51.4% below the Medical Devices & Instruments median (#72 of 810)
No single metric tells the full story. See the ICUI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
81GF Score
Get the complete analysis for ICUI
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ICUI has been successfully added to your 
